Dynamics and durability of HIV-1 neutralization are determined by viral replication

Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet available, only data from HIV-1 neutralizers—persons with HIV-1 who naturally develop broad and potent nAbs—can infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Schommers, Philipp, Kim, Dae Sung, Schlotz, Maike, Kreer, Christoph, Eggeling, Ralf, Hake, Anna, Stecher, Melanie, Park, Juyeon, Radford, Caelan E., Dingens, Adam S., Ercanoglu, Meryem S., Gruell, Henning, Odidika, Stanley, Dahlhaus, Marten, Gieselmann, Lutz, Ahmadov, Elvin, Lawong, Rene Y., Heger, Eva, Knops, Elena, Wyen, Christoph, Kümmerle, Tim, Römer, Katja, Scholten, Stefan, Wolf, Timo, Stephan, Christoph, Suárez, Isabelle, Raju, Nagarajan, Adhikari, Anurag, Esser, Stefan, Streeck, Hendrik, Duerr, Ralf, Nanfack, Aubin J., Zolla-Pazner, Susan, Geldmacher, Christof, Geisenberger, Otto, Kroidl, Arne, William, Wiston, Maganga, Lucas, Ntinginya, Nyanda Elias, Georgiev, Ivelin S., Vehreschild, Jörg J., Hoelscher, Michael, Fätkenheuer, Gerd, Lavinder, Jason J., Bloom, Jesse D., Seaman, Michael S., Lehmann, Clara, Pfeifer, Nico, Georgiou, George, Klein, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667105/
https://www.ncbi.nlm.nih.gov/pubmed/37957379
http://dx.doi.org/10.1038/s41591-023-02582-3

Ejemplares similares

Ejemplares similares